New York, NY -- (SBWire) -- 06/18/2019 --This report on Circulating Tumor Cell (CTC) Diagnostics Market offers a detailed analysis of the trends along with the prospective growth of the same in the forecasted period. It evaluates the pricing, demand, growth, revenue, size and gross margin of the industry. For this study, the historical data has been collected from the years 2016 and 2017, taking the year 2018 as the base year and drawing a forecast for the years 2019 to 2026. The industry has seen a stable growth recently and its demand is projected to rise rapidly in the future.

Cancer is a notorious disease that can affect any part of the body. In some cases, cancer can quickly generate abnormal cells that can travel to places far from its primary site and can eventually assault other parts of the body and as a consequence spread to other organs. This invasive process is known as metastases.

Cells released from the primary tumor or it metastases are known as circulating tumor cells (CTCs). These cells are usually tumor cells and are found circulating in the peripheral blood. CTCs were discovered by the Australian pathologist John Ashworth in 1869. There were a lot of technical challenges in studying these tumor cells. There have been tremendous technical developments in cell enrichment, isolation, molecular analysis and bioinformatics in this area. CTCs have been enriched using unique and specific cell-surface markers or other novel physical characteristics such as cell size or deformability. Patients' CTCs can be grown in vitro or in immunocompromised mice, and then further studied.

FREE SAMPLE COPY: (Customized As Per Your Business Need + CAGR And Gross Market Value Included)@ https://www.marketexpertz.com/sample-enquiry-form/42206

Major Players in Circulating Tumor Cell (CTC) Diagnosticsy Market are:
ADNAGEN, ADVANCED CELL DIAGNOSTICS, APOCELL, AVIVA BIOSCIENCES, BIOCEP LTD., BIOCEPT INC., BIOFLUIDICA MICROTECHNOLOGIES LLC, CANOPUS BIOSCIENCES, CELLMAX LIFE, CELLTRAFIX INC., CELULA, CLEARBRIDGE BIOMEDICS, CREATV MICROTECH INC, CYNVENIO BIOSYSTEMS INC., CYTOTRACK, EPIC BIOSCIENCES, FLUXION BIOSCIENCES, GREINER BIO-ONE GMBH, IKONISYS INC., IVDIAGNOSTICS INC, JANSSEN DIAGNOSTICS, MENARINI-SILICON BIOSYSTEMS, MILTENYI BIOTEC , NANOSTRING TECHNOLOGIES INC., NATURAL NANO INC., RARECELLS, SCREENCELL, STEMCELL TECHNOLOGIES, SYNERGEX CORP., SYSMEX CORP., VITATEX INC.

Metastasis is the major cause of cancer deaths today, and CTCs may be the facilitate metastases. As CTCs circulate and spread in the body, the disease gets a hold of different parts of the body and can potentially become challenging from diagnostic and therapeutic perspectives. In this situation, CTCs can play a very important role as they allow for a specific detection of metastasis, and at an early stage when it is less invasive and treatment modalities can be effectively implemented. The development of noninvasive ways to detect and monitor tumors continues to be a challenge in cancer research. CTCs and CTC associated molecules can be useful.

In addition, the molecular characterization of CTCs enables implementation of efficient treatment strategies. One such thought is that removing CTCs from the blood will limit metastases after surgery or therapy. Molecular characterization can help in developing new and novel technologies for CTC detection, isolation, enumeration, and later genetic or proteomic analysis.

Recently, CTCs, as an area of cancer research, have rapidly been gaining popularity because it is a noninvasive diagnostic and prognostic tool for patient treatment and predicting cancer progression. Many technologies for the detection, characterization and analysis of CTCs have recently entered the market.

There is a critical need for non-invasive prognostic tools for detecting cancer. Circulating tumor cell technology recovers and detects tumor cells present in the peripheral blood. These technologies can help in improving patient care and also offer better treatment outcomes. CTC as a technology can revolutionize cancer diagnosis, prognosis and treatment because it offers highly sensitive, targeted, reproducible and non-invasive assays.

Buy Now (Customized report delivered as per your Business requirement) @ https://www.marketexpertz.com/checkout-form/42206

Report Includes:
- 118 Tables
- An overview of the global market for cancer diagnostics, based on circulating tumor cells, which are used to increase understanding of tumor cell biology and metastatic cancer as a disease.
- Analyses of global market trends, with data from 2016, estimates from 2017, and projections of compound annual growth rates (CAGRs) through 2022.
- Discussions covering the advantages and disadvantages of CTC enrichment techniques.
- Estimations of cancer incidence, cancer deaths, new cases by type in the United States, and breast cancer statistics and facts.
- Examination of growth opportunities and drivers in the CTC market and recent breakthroughs in research, along with a patent analysis.
- Information about the clinical testing, prognostic, and monitoring markets for CTCs in cancer.
- Coverage of approved CTC tests and their markets, and the regulatory environment.
- Company profiles of major players across various product categories, including Cytotrack, Menarini-Silicon Biosystems And A. Menarini Diagnostics (Veridex Llc), Greiner Bio-One Gmbh, Cynvenio Biosystems Inc., Biofluidica Microtechnologies Llc and Advanced Cell Diagnostics

Key Points From Table of Contents:
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Intended Audience
Scope of the Study
Methodology
Information Sources
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Circulating Tumor Cells
Cancer
Recent Advances in Technology
Invasive Power
Circulating Tumor Cells
Phenotypic Characteristics
CTC Clusters
CTC Detection
Cancer Stem Cells (CSCs)
Circulating Tumor Cells- Potential Uses
Proliferative Activity
Epithelial Marker Genes on Circulating Tumor Cells
Circulating Tumor Cells and Stem Cell-Like Phenotype
CTCs and Primary Tumor Cells: Comparison
Metastasis
Future Directions
Metastatic Development in Cancer Patients
Circulating Tumor Cell Migration
Important Markers of Distant Metastasis
Circulating Tumor Cell Detection
Methods
CellSearch Method
Epic Sciences Method
Maintrac
ISET Test
Challenges for Detection
Continued…..

Browse Complete report description And Full TOC @ https://www.marketexpertz.com/industry-overview/circulating-tumor-cell-ctc-diagnostics-market

About MarketExpertz
Planning to invest in market intelligence products or offerings on the web? Then marketexpertz has just the thing for you - reports from over 500 prominent publishers and updates on our collection daily to empower companies and individuals catch-up with the vital insights on industries operating across different geography, trends, share, size and growth rate. There's more to what we offer to our customers. With marketexpertz you have the choice to tap into the specialized services without any additional charges.

Contact Us:
John Watson
Head of Business Development
Market Expertz | Web: www.marketexpertz.com
Direct Line: +1-800-819-3052
E-mail: sales@marketexpertz.com